163 related articles for article (PubMed ID: 10590404)
21. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria.
Haq RU; Fries TJ; Pendlebury WW; Kenny MJ; Badger GJ; Tandan R
Arch Neurol; 2000 Dec; 57(12):1745-50. PubMed ID: 11115240
[TBL] [Abstract][Full Text] [Related]
22. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
[TBL] [Abstract][Full Text] [Related]
23. Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy?
Garces-Sanchez M; Laughlin RS; Dyck PJ; Engelstad JK; Norell JE; Dyck PJ
Ann Neurol; 2011 Jun; 69(6):1043-54. PubMed ID: 21425185
[TBL] [Abstract][Full Text] [Related]
24. Chronic progressive steroid responsive axonal polyneuropathy: a CIDP vaariant or a primary axonal disorder?
Uncini A; Sabatelli M; Mignogna T; Lugaresi A; Liguori R; Montagna P
Muscle Nerve; 1996 Mar; 19(3):365-71. PubMed ID: 8606703
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
Lotan I; Hellman MA; Steiner I
Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
[TBL] [Abstract][Full Text] [Related]
26. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
27. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy.
Boukhris S; Magy L; Kabore R; Mabrouk T; Li Y; Sindou P; Tabaraud F; Vallat JM
Neurophysiol Clin; 2004 Apr; 34(2):71-9. PubMed ID: 15130553
[TBL] [Abstract][Full Text] [Related]
28. Membrane property changes in most distal motor axons in chronic inflammatory demyelinating polyneuropathy.
Amino H; Shibuya K; Misawa S; Sekiguchi Y; Beppu M; Suichi T; Suzuki YI; Tsuneyama A; Kuwabara S
Muscle Nerve; 2020 Feb; 61(2):238-242. PubMed ID: 31650564
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
30. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
31. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
32. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
33. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
[TBL] [Abstract][Full Text] [Related]
34. Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy.
Uncini A; Di Muzio A; De Angelis MV; Gioia S; Lugaresi A
Clin Neurophysiol; 1999 Apr; 110(4):694-8. PubMed ID: 10378740
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases.
Vallat JM; Tabaraud F; Magy L; Torny F; Bernet-Bernady P; Macian F; Couratier P
Muscle Nerve; 2003 Apr; 27(4):478-85. PubMed ID: 12661050
[TBL] [Abstract][Full Text] [Related]
36. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
[TBL] [Abstract][Full Text] [Related]
37. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
38. Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Attarian S; Franques J; Elisabeth J; Trébuchon A; Duclos Y; Wybrecht D; Verschueren A; Salort-Campana E; Pouget J
Muscle Nerve; 2015 Apr; 51(4):541-8. PubMed ID: 25571892
[TBL] [Abstract][Full Text] [Related]
39. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.
Stanton M; Pannoni V; Lewis RA; Logigian EL; Naguib D; Shy ME; Cleland J; Herrmann DN
Muscle Nerve; 2006 Oct; 34(4):417-22. PubMed ID: 16823858
[TBL] [Abstract][Full Text] [Related]
40. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.
Tan CY; Arumugam T; Razali SNO; Yahya MA; Goh KJ; Shahrizaila N
J Clin Neurosci; 2018 Nov; 57():198-201. PubMed ID: 30145079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
